This procedure concerns the drug thalidomide, which was used to treat morning sickness in pregnant women in the late 1950s and early 1960s. It caused severe birth defects and is now banned in most countries.
The procedure likely addresses the ongoing impact of thalidomide, including support for survivors and measures to prevent similar tragedies.